7901 - 7925 of 9038 Results
Title
Year
-
OPENTitle: Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based ReviewJournal Name: DystoniaPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/dyst.2022.10655Best OA location URL: https://www.frontierspartnerships.org/articles/10.3389/dyst.2022.10655/pdfCitation Count: 9
-
OPENTitle: Assessing the Quality and Reliability of COVID-19 Information on Patient Organization WebsitesJournal Name: Frontiers in CommunicationPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcomm.2021.716683Best OA location URL: https://www.frontiersin.org/journals/communication/articles/10.3389/fcomm.2021.716683/pdfCitation Count: 8
-
OPENTitle: Tele-Yoga for the Management of Cervical Dystonia: A Safety and Feasibility TrialJournal Name: DystoniaPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/dyst.2021.10015Best OA location URL: https://www.frontierspartnerships.org/articles/10.3389/dyst.2021.10015/pdfCitation Count: 0
-
OPENTitle: DNA Sequence Analysis for Brain Disorder Using Deep Learning and Secure StorageJournal Name: Computers, Materials & ContinuaPublisher: Tech Science PressVol: 71Issue #: 3Start Page: 5949End Page: 5962Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.32604/cmc.2022.022028Best OA location URL: https://www.techscience.com/cmc/v71n3/46465/pdfCitation Count: 6
- Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement2021RESTRICTEDTitle: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementJournal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Publisher: Walter de Gruyter GmbHVol: 59Issue #: 10Start Page: 1653End Page: 1661Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/cclm-2020-1521Citation Count: 7
-
OPENTitle: Deep learning for Parkinson’s disease symptom detection and severity evaluation using accelerometer signalJournal Name: ESANN 2022 proceedingsPublisher: Ciaco - i6doc.comVol:Issue #:Start Page: 271End Page: 276Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.14428/esann/2022.es2022-107Best OA location URL: https://doi.org/10.14428/esann/2022.es2022-107Citation Count: 1
- The philosophy of Constantine the Philosopher of Nicaea2021RESTRICTEDTitle: The philosophy of Constantine the Philosopher of NicaeaJournal Name: Byzantinische ZeitschriftPublisher: Walter de Gruyter GmbHVol: 114Issue #: 1Start Page: 139End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/bz-2021-9006Citation Count: 0
-
OPENTitle: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s diseaseJournal Name: Medizinische GenetikPublisher: Walter de Gruyter GmbHVol: 34Issue #: 2Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1515/medgen-2022-2127Best OA location URL: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2127/pdfCitation Count: 8
-
OPENTitle: Supplement (online only): Proceedings of the 14th Göttingen Meeting of the German Neuroscience Society 2021Journal Name: NeuroforumPublisher: Walter de Gruyter GmbHVol: 27Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1515/nf-2021-2003Best OA location URL: https://www.degruyter.com/document/doi/10.1515/nf-2021-2003/pdfCitation Count: 0
-
OPENTitle: Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson’s DiseaseJournal Name: NeurologyPublisher: Touch Medical Media, Ltd.Vol: 17Issue #: 1Start Page: 36End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.17925/usn.2021.17.1.36Best OA location URL: https://touchneurology.com/wp-content/uploads/sites/3/2021/07/touchNEURO_17.1_pp36-47.pdfCitation Count: 1
-
OPENTitle: Am I My Cousin's Keeper? A Proposal to Protect Relatives of Genetic Database SubjectsJournal Name: Indiana Health Law ReviewPublisher: IUPUI University LibraryVol: 18Issue #: 1Start Page: 1End Page: 55Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18060/25052Best OA location URL: https://journals.iupui.edu/index.php/ihlr/article/download/25052/23545Citation Count: 3
-
OPENTitle: Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order–Disorder Transition Upon ActivationJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 435Issue #: 12Start Page: 167999End Page: 167999Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.jmb.2023.167999Best OA location URL: https://doi.org/10.1016/j.jmb.2023.167999Citation Count: 23
- A high dose tango intervention for people with Parkinson's disease (PwPD)2021RESTRICTEDTitle: A high dose tango intervention for people with Parkinson's disease (PwPD)Journal Name: Advances in Integrative MedicinePublisher: Elsevier BVVol: 8Issue #: 4Start Page: 272End Page: 277Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.aimed.2021.07.005Citation Count: 6
- Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursing2021RESTRICTEDTitle: Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursingJournal Name: Archives of Psychiatric NursingPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 284End Page: 289Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.apnu.2021.03.006Citation Count: 8
- In-Home Falls Risk Assessment in Parkinson Disease: A Guide for Clinicians2021OPENTitle: In-Home Falls Risk Assessment in Parkinson Disease: A Guide for CliniciansJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 102Issue #: 10Start Page: 2051End Page: 2054Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2021.04.001Citation Count: 3
- A conversation with Judith Campisi: Leader in the field of aging research2021OPENTitle: A conversation with Judith Campisi: Leader in the field of aging researchJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 69Issue #:Start Page: 101366End Page: 101366Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2021.101366Citation Count: 2
-
OPENTitle: Data imputation and compression for Parkinson's disease clinical questionnairesJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 114Issue #:Start Page: 102051End Page: 102051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.artmed.2021.102051Best OA location URL: https://hal.science/hal-02570967/documentCitation Count: 30
-
OPENTitle: Subtle anomaly detection: Application to brain MRI analysis of de novo Parkinsonian patientsJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 125Issue #:Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.artmed.2022.102251Best OA location URL: https://doi.org/10.1016/j.artmed.2022.102251Citation Count: 15
- Quality of life after hospitalization predicts one-year readmission risk in a large Swiss cohort of medical in-patients2021RESTRICTEDTitle: Quality of life after hospitalization predicts one-year readmission risk in a large Swiss cohort of medical in-patientsJournal Name: Quality of Life ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 7Start Page: 1863End Page: 1871Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11136-021-02867-5Citation Count: 3
- Exogenous Tetranectin Alleviates Pre-formed-fibrils-induced Synucleinopathies in SH-SY5Y Cells by Activating the Plasminogen Activation System2022RESTRICTEDTitle: Exogenous Tetranectin Alleviates Pre-formed-fibrils-induced Synucleinopathies in SH-SY5Y Cells by Activating the Plasminogen Activation SystemJournal Name: Neurochemical ResearchPublisher: Springer Science and Business Media LLCVol: 47Issue #: 10Start Page: 3192End Page: 3201Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11064-022-03673-2Citation Count: 5
- Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRI2022RESTRICTEDTitle: Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRIJournal Name: NeuroinformaticsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 4Start Page: 879End Page: 896Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12021-022-09565-8Citation Count: 5
- Association of Total Bilirubin with Motor Signs in Early Parkinson’s Disease in LRRK2 Variant Carriers2022RESTRICTEDTitle: Association of Total Bilirubin with Motor Signs in Early Parkinson’s Disease in LRRK2 Variant CarriersJournal Name: Journal of Molecular NeurosciencePublisher: Springer Science and Business Media LLCVol: 72Issue #: 11Start Page: 2338End Page: 2344Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12031-022-02067-xCitation Count: 2
- Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s Disease2021RESTRICTEDTitle: Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 8Start Page: 3641End Page: 3652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02371-4Citation Count: 20
- Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on Neuroinflammation2021RESTRICTEDTitle: Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on NeuroinflammationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 59Issue #: 2Start Page: 1140End Page: 1150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02625-1Citation Count: 19
- No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjects2021RESTRICTEDTitle: No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjectsJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 35Issue #: 11Start Page: 1187End Page: 1192Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12149-021-01657-wCitation Count: 1